PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In this study, we implemented an in vitro model of NAFLD with genetic susceptibility, being homozygotes for the PNPLA3 I148M sequence variant, the strongest genetic determinant of NAFLD.